Key result
Acute coronary syndrome patients who remain event-free in the first year still face a persistent risk, with up to 1 in 5 suffering a vascular event in the subsequent 3 years.
Patients with ACS remain at significant risk of vascular events even after the first year, highlighting the potential need for prolonged anticoagulant therapy.
Acute coronary syndromes (ACS) are a major cause of morbidity and mortality. Despite the use of optimal medical therapy and revascularisation there remains a significant risk of vascular events. Registry data indicates a persistent risk even in patients who are event free in the first year following ACS, with as many as 1 in 5 patients suffering a vascular event in the subsequent 3 years.1
No takes yet. Share an insight, caveat, or question.
Onwordi et al. (2018) studied this question. Acute coronary syndrome patients who remain event-free in the first year still face a persistent risk, with up to 1 in 5 suffering a vascular event in the subsequent 3 years.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: